32.74
price up icon0.31%   0.10
pre-market  Pre-market:  32.11   -0.63   -1.92%
loading

Genmab Adr Stock (GMAB) Forecast

The Genmab Adr (GMAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $49.25, representing a +50.42% increase from the current price of $32.74. The highest analyst price target is $51.20, and the lowest is $47.30.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GMAB Price Target
Average 52.76 (+61.16% Upside)
loading

Is Genmab Adr (GMAB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 75.88 Sell
STOCH(9,6) 92.16 Sell
STOCHRSI(14) 40.38 Neutral
MACD(12,26) 1.8448 Buy
ADX(14) 52.93 Buy
William %R -16.64 Sell
CCI(14) 83.49 Neutral
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
31.40
Buy
31.65
Buy
MA20
29.89
Buy
30.20
Buy
MA50
26.40
Buy
27.39
Buy
MA100
23.97
Buy
25.15
Buy
MA200
22.26
Buy
24.00
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, GMAB could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on GMAB, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 75.88 indicates that GMAB is overbought. This suggests that GMAB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 92.16 indicates that GMAB is oversold. This means that GMAB price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.38 indicates that GMAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 52.93 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 83.49 indicates that GMAB is still overbought but not to an extreme extent.

Long-term GMAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Genmab Adr financial reports and earnings history, Genmab Adr (GMAB) stock could reach $43.21 by 2030, $84.80 by 2040 and $120.26 by 2050. See the projected annual prices until 2050 of the Genmab Adr stock below:

  • Genmab Adr (GMAB) is expected to reach an average price of $63.75 in 2035, with a high prediction of $65.66 and a low estimate of $61.16. This indicates an $94.71% rise from the last recorded price of $32.74.
  • Genmab Adr (GMAB) stock is projected to chart a bullish course in 2040, with an average price target of $77.53, representing an $136.80% surge from its current level. The forecast ranges from a conservative $77.04 to a sky-high $84.80.
  • Our analysts predict Genmab Adr (GMAB) to jump 211.51% by 2045, soaring from $101.96 to an average price of $101.99, potentially reaching $105.57. While $101.96 is the low estimate, the potential upside is significant.
  • Genmab Adr (GMAB) stock is expected to climb by 2050, reaching an average of $117.11, a $257.68% jump from its current level. However, a wide range of estimates exists, with high and low targets of $120.26 and $115.90, respectively, highlighting the market's uncertainty.

Genmab Adr Stock (GMAB) Year by Year Forecast

Genmab Adr Stock (GMAB) Price Forecast for 2025

Genmab Adr Stock (GMAB) is expected to reach an average price of $41.00 in 2025, with a high prediction of $54.15 and a low estimate of $27.86. This indicates an +25.24% rise from the last recorded price of $32.74.
Month Average Low High Change from today's price
November, 2025 $51.16 $47.30 $51.20 +56.25%
December, 2025 $53.32 $50.47 $54.15 +62.86%

Genmab Adr Stock (GMAB) Price Forecast for 2026

The predicted value for Genmab Adr (GMAB) in 2026 is set at an average of $52.76. Estimates vary from a peak of $62.57 to a trough of $42.95, indicating an +61.16% surge from the present price of $32.74.
Month Average Low High Change from today's price
January, 2026 $52.42 $52.35 $57.52 +60.11%
February, 2026 $46.70 $46.16 $54.76 +42.64%
March, 2026 $45.93 $42.95 $48.09 +40.29%
April, 2026 $49.84 $44.46 $50.29 +52.23%
May, 2026 $52.37 $48.53 $52.60 +59.96%
June, 2026 $56.13 $52.53 $58.13 +71.45%
July, 2026 $56.54 $53.90 $57.77 +72.70%
August, 2026 $59.98 $56.11 $61.03 +83.21%
September, 2026 $57.51 $57.47 $62.57 +75.64%
October, 2026 $56.80 $55.54 $58.61 +73.47%
November, 2026 $58.34 $55.64 $60.56 +78.21%
December, 2026 $52.34 $51.62 $61.01 +59.86%

Genmab Adr Stock (GMAB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Genmab Adr (GMAB) is $47.47, with a high forecast of $54.19 and a low forecast of $40.75. This indicates an +44.99% increase from the last price of $32.74.
Month Average Low High Change from today's price
January, 2027 $53.60 $49.69 $54.19 +63.70%
February, 2027 $47.50 $47.35 $54.18 +45.07%
March, 2027 $46.31 $45.62 $49.47 +41.44%
April, 2027 $45.91 $44.21 $48.84 +40.22%
May, 2027 $50.93 $46.55 $51.95 +55.55%
June, 2027 $45.21 $45.06 $53.01 +38.09%
July, 2027 $44.74 $41.84 $45.60 +36.65%
August, 2027 $46.89 $40.75 $46.92 +43.22%
September, 2027 $50.37 $45.63 $50.99 +53.86%
October, 2027 $50.67 $49.12 $52.93 +54.77%
November, 2027 $52.31 $49.15 $52.55 +59.78%
December, 2027 $51.48 $46.34 $52.53 +57.25%

Genmab Adr Stock (GMAB) Price Forecast for 2028

In 2028, Genmab Adr (GMAB) is projected to reach an average price of $56.40, with a high projection of $62.69 and a low estimate of $50.12. This indicates an +72.27% rise from the last price of $32.74.
Month Average Low High Change from today's price
January, 2028 $55.02 $50.12 $55.02 +68.06%
February, 2028 $61.69 $54.20 $61.73 +88.44%
March, 2028 $57.66 $57.07 $62.69 +76.10%
April, 2028 $54.24 $53.81 $58.98 +65.66%
May, 2028 $52.91 $52.36 $55.57 +61.60%
June, 2028 $51.42 $50.20 $53.83 +57.05%
July, 2028 $57.24 $51.39 $57.30 +74.82%
August, 2028 $57.41 $55.17 $58.67 +75.35%
September, 2028 $54.41 $54.38 $58.20 +66.19%
October, 2028 $53.63 $52.74 $55.41 +63.80%
November, 2028 $53.47 $53.38 $58.74 +63.32%
December, 2028 $54.44 $51.85 $55.68 +66.28%

Genmab Adr Stock (GMAB) Price Forecast for 2029

The 2029 price forecast for Genmab Adr Stock (GMAB) is $47.09 on average, with a high prediction of $55.02 and a low estimate of $39.16. This represents an +43.83% increase from the previous price of $32.74.
Month Average Low High Change from today's price
January, 2029 $51.53 $51.43 $55.02 +57.40%
February, 2029 $44.77 $44.38 $52.19 +36.75%
March, 2029 $49.24 $44.14 $49.33 +50.41%
April, 2029 $48.81 $46.69 $49.35 +49.09%
May, 2029 $48.25 $46.39 $49.52 +47.39%
June, 2029 $44.53 $44.00 $46.67 +36.03%
July, 2029 $44.59 $43.10 $46.28 +36.21%
August, 2029 $46.85 $45.26 $48.77 +43.09%
September, 2029 $45.18 $44.46 $47.46 +37.99%
October, 2029 $39.82 $39.16 $46.07 +21.62%
November, 2029 $41.81 $39.53 $42.68 +27.70%
December, 2029 $42.37 $41.18 $43.19 +29.41%

Genmab Adr Stock (GMAB) Price Forecast for 2030

Genmab Adr Stock (GMAB) is expected to reach an average price of $50.14 in 2030, with a high forecast of $60.82 and a low forecast of $39.45. This signifies an +53.14% surge from the last price of $32.74.
Month Average Low High Change from today's price
January, 2030 $43.15 $40.97 $43.21 +31.81%
February, 2030 $44.31 $42.76 $44.48 +35.35%
March, 2030 $46.29 $44.12 $46.93 +41.39%
April, 2030 $44.94 $44.16 $46.18 +37.27%
May, 2030 $46.00 $43.92 $46.20 +40.49%
June, 2030 $45.55 $45.29 $48.43 +39.11%
July, 2030 $44.60 $39.45 $47.27 +36.21%
August, 2030 $46.24 $42.95 $46.60 +41.23%
September, 2030 $52.31 $47.34 $52.77 +59.77%
October, 2030 $55.52 $51.75 $55.97 +69.57%
November, 2030 $58.96 $55.76 $59.81 +80.10%
December, 2030 $60.74 $58.09 $60.82 +85.53%
$23.34
price up icon 4.71%
$85.38
price down icon 2.05%
$106.28
price up icon 0.21%
$161.81
price down icon 0.31%
biotechnology ONC
$351.09
price up icon 2.77%
Cap:     |  Volume (24h):